[1] Malherbe, C., De Gasparo, M., De Hertogh, R. and Hoet, J.J. (1969) Circadian Variations of Blood Sugar and Plasma Insulin Levels in Man. Diabetologia, 5, 397-404. http://dx.doi.org/10.1007/BF00427978
[2] Whichelow, M.J., Sturge, R.A., Keen, H., Jarrett, R.J., Stimmler, L. and Grainger, S. (1974) Diurnal Variation in Response to Intravenous Glucose. British Medical Journal, 1, 488-491.
http://dx.doi.org/10.1136/bmj.1.5906.488
[3] Wu, M.S., Ho, L.T., Jap, T.S., Kwok, C.F. and Chen, J.J. (1986) Diurnal Variation of Insulin Clearance and Sensitivity in Normal Man. Proceedings of the National Science Council, Republic of China, Part B, Life Sciences, 10, 64-69.
[4] Bolli, G.B., De Feo, P., De Cosmo, S., Perriello, G., Ventura, M.M., Calcinaro, F., Lolli, C., Campbell, P., Brunetti, P. and Gerich, J.E. (1984) Demonstration of a Dawn Phenomenon in Normal Human Volunteers. Diabetes, 33, 1150-1153. http://dx.doi.org/10.2337/diab.33.12.1150
[5] Nielsen, M.F., Dinneen, S., Basu, A., Basu, R., Alzaid, A. and Rizza, R.R. (1998) Failure of Nocturnal Changes in Growth Hormone to Alter Carbohydrate Tolerance the Following Morning. Diabetologia, 41, 1064-1072. http://dx.doi.org/10.1007/s001250051031
[6] Fineberg, S. and Merimee, T.J. (1974) Acute Metabolic Effects of Human Growth Hormone. Diabetes, 23, 499-504. http://dx.doi.org/10.2337/diab.23.6.499
[7] Sassin, J.F., Parker, D.C., Mace, J.W., Gotlin, R.W., Johnson, L.C. and Rossman, L.G. (1969) Human Growth Hormone Release: Relation to Slow-Wave Sleep and Sleep-Walking Cycles. Science, 165, 513-515. http://dx.doi.org/10.1126/science.165.3892.513
[8] Campbell, P.J., Bolli, G.B., Cryer, P.E. and Gerich, J.E. (1985) Pathogenesis of the Dawn Phenomenon in Patients with Insulin-Dependent Diabetes Mellitus. Accelerated Glucose Production and Impaired Glucose Utilization Due to Nocturnal Surges in Growth Hormone Secretion. New England Journal of Medicine, 312, 1473-1479. http://dx.doi.org/10.1056/NEJM198506063122302
[9] Hwu, C.M., Kwok, C.F., Lai, T.Y., Shih, K.C., Lee, T.S., Hsiao, L.C., Lee, S.H., Fang, V.S. and Ho, L.T. (1997) Growth Hormone (GH) Replacement Reduces Total Body Fat and Normalizes Insulin Sensitivity in GH-Deficient Adults: A Report of One-Year Clinical Experience. The Journal of Clinical Endocrinology and Metabolism, 82, 3285-3292. http://dx.doi.org/10.1210/jc.82.10.3285
[10] Shih, K.C., Ho, L.T., Kou, H.F., Liu, P.C., Hsiao, L.C., Li, S.H., Liu, Y.F. and Wu, M.S. (1992) Diurnal Variation in Insulin Sensitivity in NIDDM Patients and Normal Subjects. Journal of the Formosan Medical Association, 91, 263-269.
[11] Yalow, R.S., Goldsmith, S.J. and Berson, S.A. (1969) Influence of Physiologic Fluctuations in Plasma Growth Hormone on Glucose Tolerance. Diabetes, 18, 402-408. http://dx.doi.org/10.2337/diab.18.6.402
[12] Hartman, M.L., Faria, A.C., Vance, M.L., Johnson, M.L., Thorner, M.O. and Veldhuis, J.D. (1991) Temporal Structure of in Vivo Growth Hormone Secretory Events in Humans. American Journal of Physiology, 260, E101-E110.
[13] Butler, P., Kryshak, E. and Rizza, R. (1991) Mechanism of Growth Hormone-Induced Postprandial Carbohydrate Intolerance in Humans. American Journal of Physiology, 260, E513-E520.
[14] Ho, L.T., Chang, Z.Y., Wang, J.T., Li, S.H., Liu, Y.F., Chen, Y.D. and Reaven, G.M. (1990) Insulin Insensitivity in Offspring of Parents with Type 2 Diabetes Mellitus. Diabetic Medicine, 7, 31-34.
http://dx.doi.org/10.1111/j.1464-5491.1990.tb01303.x
[15] Noma, A., Okabe, H. and Kita, M. (1973) A New Colorimetric Micro-Determination of Free Fatty Acids in Serum. Clinica Chimica Acta, 43, 317-320. http://dx.doi.org/10.1016/0009-8981(73)90468-3
[16] MacGorman, L.R., Rizza, R.A. and Gerich, J.E. (1981) Physiological Concentrations of Growth Hormone Exert Insulin-Like and Insulin Antagonistic Effects on Both Hepatic and Extrahepatic Tissues in Man. The Journal of Clinical Endocrinology and Metabolism, 53, 556-559. http://dx.doi.org/10.1210/jcem-53-3-556
[17] Shih, K.C., Hsieh, S.H., Kwok, C.F., Hwu, C.M., Hsieh, P.S. and Ho, L.T. (2013) Effect of Growth Hormone on Dawn Phenomenon in Patients with Type 2 Diabetes. Growth Factors, 31, 66-73.
http://dx.doi.org/10.3109/08977194.2013.772996
[18] Shih, K.C., Liu, L.Y., Kwok, C.F., Hwu, C.M., Juan, C.C., Hsu, Y.P. and Ho, L.T. (2007) Effect of Reversing Dark-Light Cycles on Normal Diurnal Variation and Related Metabolic Disturbance in Rats. Chinese Journal of Physiology, 50, 69-76.
[19] Lindberg-Larsen, R., M?ller, N., Schmitz, O., Nielsen, S., Andersen, M., Orskov, H. and J?rgensen, J.O. (2007) The Impact of Pegvisomant Treatment on Substrate Metabolism and Insulin Sensitivity in Patients with Acromegaly. The Journal of Clinical Endocrinology and Metabolism, 92, 1724-1728.
http://dx.doi.org/10.1210/jc.2006-2276
[20] Campbell, P.J., Bolli, G.B. and Gerich, J.E. (1988) Prevention of the Dawn Phenomenon (Early Morning Hyperglycemia) in Insulin Dependent Diabetes Mellitus by Bedtime Intranasal Administration of Long Acting Somatostatin Analog. Metabolism, 37, 34-37. http://dx.doi.org/10.1016/0026-0495(88)90026-1
[21] M?ller, N. and Jorgensen, J.O. (2009) Effects of Growth Hormone on Glucose, Lipid and Protein Metabolism in Human Subjects. Endocrine Reviews, 30, 152-177. http://dx.doi.org/10.1210/er.2008-0027
[22] Krusenstjerna-Hafstr?m, T., Clasen, B.F., M?ller, N., Jessen, N., Pedersen, S.B., Christiansen, J.S. and J?rgensen, J.O. (2011) Growth Hormone (GH)-Induced Insulin Resistance is Rapidly Reversible: An Experimental Study in GH-Deficient Adults. The Journal of Clinical Endocrinology and Metabolism, 96, 2548-2557. http://dx.doi.org/10.1210/jc.2011-0273
[23] Perriello, G., De Feo, P., Torlone, E., Fanelli, C., Santeusanio, F., Brunetti, P. and Bolli, G.B. (1990) Nocturnal Spikes of Growth Hormone Secretion Cause the Dawn Phenomenon in Type 1 (Insulin Dependent) Diabetes Mellitus by Decreasing Hepatic (and Extrahepatic) Sensitivity to Insulin in the Absence of Insulin Waning. Diabetologia, 33, 52-59. http://dx.doi.org/10.1007/BF00586461
[24] Dux, S., White, N.H., Skor, D.A. and Santiago, J.V. (1985) Insulin Clearance Contributes to the Variability of Nocturnal Insulin Requirement in Insulin-Dependent Diabetes Mellitus. Diabetes, 34, 1260-1265. http://dx.doi.org/10.2337/diab.34.12.1260
[25] J?rgensen, J.O. (1991) Human Growth Hormone Replacement Therapy: Pharmacological and Clinical Aspects. Endocrine Reviews, 2, 189-207. http://dx.doi.org/10.1210/edrv-12-3-189
[26] Bright, G.M., Melton, T.W., Rogol, A.D. and Reaven, G.M. (1980) Failure of Cortisol Blockade to Inhibit Early Morning Increases in Basal Insulin Requirements in Fasting Insulin-Dependent Diabetics. Diabetes, 29, 662-664. http://dx.doi.org/10.2337/diab.29.8.662
[27] Skor, D.A., White, N.H., Thomas, L., Shan, S.D., Cryer, P.E. and Santiago, J.V. (1983) Examination of the Role of the Pituitary-Adrenocortical Axis, Counterregulatory Hormones, and Insulin Clearance in Variable Nocturnal Insulin Requirements in Insulin-Dependent Diabetes. Diabetes, 32, 403-407. http://dx.doi.org/10.2337/diab.32.5.403
[28] Xu, J. and Messina, J.K. (2009) Crosstalk between Growth Hormone and Insulin Signaling. Vitamins & Hormones, 80, 125-153. http://dx.doi.org/10.1016/S0083-6729(08)00606-7
[29] Domenici, F.P., Argentino, D.P., Mu?oz, M.C., Miquet, J.G., Sotelo, A.I. and Turyn, D. (2005) Influence of the Crosstalk between Growth Hormone and Insulin Signaling on the Modulation of Insulin Sensitivity. Growth Hormone & IGF Research, 15, 324-336. http://dx.doi.org/10.1016/j.ghir.2005.07.001